Page last updated: 2024-09-05

opc 4392 and bifeprunox

opc 4392 has been researched along with bifeprunox in 1 studies

Compound Research Comparison

Studies
(opc 4392)
Trials
(opc 4392)
Recent Studies (post-2010)
(opc 4392)
Studies
(bifeprunox)
Trials
(bifeprunox)
Recent Studies (post-2010) (bifeprunox)
161030112

Protein Interaction Comparison

ProteinTaxonomyopc 4392 (IC50)bifeprunox (IC50)
D(2) dopamine receptorHomo sapiens (human)0.0029

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forbes, RA; Kikuchi, T; Kitagawa, H; McQuade, RD; Stark, A; Tadori, Y1

Other Studies

1 other study(ies) available for opc 4392 and bifeprunox

ArticleYear
Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912.
    European journal of pharmacology, 2007, Nov-28, Volume: 574, Issue:2-3

    Topics: Animals; Aripiprazole; Benzoxazoles; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Humans; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Schizophrenia

2007